Literature DB >> 31439722

Association of novel measures of sleep disturbances with blood pressure: the Multi-Ethnic Study of Atherosclerosis.

John S Kim1, Ali Azarbarzin2, Rui Wang3,4, Ina E Djonlagic5, Naresh M Punjabi6, Phyllis C Zee7, Brian B Koo8, Elsayed Z Soliman9, Magdy Younes10, Susan Redline2,11.   

Abstract

BACKGROUND: Mechanisms underlying blood pressure (BP) changes in obstructive sleep apnoea (OSA) are incompletely understood. We assessed the associations between BP and selected polysomnography (PSG) traits: sleep depth, airflow limitation measurements and OSA-specific hypoxic burden.
METHODS: This cross-sectional analysis included 2055 participants from the Multi-Ethnic Study of Atherosclerosis who underwent PSG and BP measurements in 2010-2013. Sleep depth was assessed using the 'OR product', a continuous measure of arousability. Airflow limitation was assessed by duty cycle (Ti/Tt) and % of breaths with flow limitation, and hypoxia by 'hypoxic burden'. Primary outcomes were medication-adjusted systolic BP (SBP) and diastolic BP (DBP). We used generalised linear models adjusted for age, sex, race/ethnicity, smoking, education, body mass index, alcohol use, periodic limb movements and alternative physiological disturbances.
RESULTS: The sample had a mean age of 68.4 years and apnoea-hypopnoea index of 14.8 events/hour. Sleep depth was not significantly associated with BP. Every 1 SD increment in log-transformed non-rapid eye movement duty cycle was associated with 0.9% decrease in SBP (95% CI: 0.1% to 1.6%), even after adjusting for sleep depth and hypoxic burden. Every 1 SD increment in log-transformed hypoxic burden was associated with a 1.1% increase in SBP (95% CI: 0.1% to 2.1%) and 1.9% increase in DBP (95% CI: 1.0% to 2.8%) among those not using hypertension medications.
CONCLUSIONS: Higher duty cycle was associated with lower SBP overall and hypoxic burden with higher SBP and DBP among non-BP medication users. These findings suggest changes in both respiratory effort and oxygenation during sleep influence BP. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  duty cycle; hypertension; hypoxia; inspiratory flow limitation; sleep apnoea

Mesh:

Year:  2019        PMID: 31439722     DOI: 10.1136/thoraxjnl-2019-213533

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

1.  Proteomic biomarkers of sleep apnea.

Authors:  Aditya Ambati; Yo-El Ju; Ling Lin; Alexander N Olesen; Henriette Koch; Julien Jacques Hedou; Eileen B Leary; Vicente Peris Sempere; Emmanuel Mignot; Shahrad Taheri
Journal:  Sleep       Date:  2020-11-12       Impact factor: 5.849

2.  Impaired central control of sleep depth propensity as a common mechanism for excessive overnight wake time: implications for sleep apnea, insomnia and beyond.

Authors:  Danny J Eckert; Alexander Sweetman
Journal:  J Clin Sleep Med       Date:  2020-01-14       Impact factor: 4.062

3.  Oximetry Indices in the Management of Sleep Apnea: From Overnight Minimum Saturation to the Novel Hypoxemia Measures.

Authors:  Daniel Álvarez; Gonzalo C Gutiérrez-Tobal; Fernando Vaquerizo-Villar; Fernando Moreno; Félix Del Campo; Roberto Hornero
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Sleep Apnea-Specific Hypoxic Burden and Not the Sleepy Phenotype as a Novel Measure of Cardiovascular and Mortality Risk in a Clinical Cohort.

Authors:  Reena Mehra; Ali Azarbarzin
Journal:  Am J Respir Crit Care Med       Date:  2022-01-01       Impact factor: 30.528

5.  Characteristics and reproducibility of novel sleep EEG biomarkers and their variation with sleep apnea and insomnia in a large community-based cohort.

Authors:  Magdy Younes; Ali Azarbarzin; Michelle Reid; Diego R Mazzotti; Susan Redline
Journal:  Sleep       Date:  2021-10-11       Impact factor: 6.313

6.  A composite sleep and pulmonary phenotype predicting hypertension.

Authors:  Ruitong Li; Michael Rueschman; Daniel J Gottlieb; Susan Redline; Tamar Sofer
Journal:  EBioMedicine       Date:  2021-06-15       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.